Fight The Fakes

Speak up about fake medicines.

Stories from the Front Line

Testing for Fake Anti-Malarials in Cameroon

Global Pharma Health Fund (GPHF) |

Testing for Fake Anti-Malarials in Cameroon
© DIFAEM

In sub-Saharan Africa, it is common to observe that less reputable traders and their fake goods are infiltrating the markets and gaining access to legal supply chains through tempting discounts. Hunting for these bargains is common procedure for consumers in Cameroon. It is a matter of survival for families with low and irregular income. This sets the a scene in which the trade of falsified and substandard quality medicines is flowering. People are not aware of the risk or just ignoring it. Even when buying cheap medicines to treat Malaria. This may end deadly when the counterfeit medicines is a complete failure with no active ingredient, filled with empty hope.

Working on the detection of falsified medicines for over fifteen years, we at the Global Pharma Health Fund (GPHF) thought we saw it all. However, in this field, surprises are always looming around the corner. Screening the quality of vital antimalarial medicines in each and every corner of the world with our Minilab, we teamed up with the German Institute for Medical Mission (DIFAEM) for some minor drug quality checks in Cameroon this year. Collected from the open markets in Yaoundé, Douala and some other towns, staff from diocesan pharmacies and faith-based healthcare centers discovered that in three leading ACT antimalarial brands, some batches contained no active pharmaceutical ingredients. Furthermore, an outdated generic SP-type of antimalarial medicine with no pyrimethamine and traces of sulfadoxine was found. Whether this was based on malpractice or outright fraud may be decided in court; the end result for patients, however, is life-taking rather than life-saving.

In one case, a vigilant pharmacist observed that some ACT tablets from the public sector supply seemed to have no therapeutic effect and sent some samples to the Presbyterian Church of Cameroon running a GPHF-Minilab as a first-line of testing. Additional compendial analysis at the Mission of Essential Supplies in Nairobi, Kenya, later confirmed that all actives, artemether and lumefantrine, were missing. In the case of another ACT medicine intended for sale in the private market sector, the spurious batch contained no dihydroartemisinin or piperaquine phosphate. The packaging and labelling were close to perfect, however, the tablets had some apparent flaws, most likely intentionally, as dealers in fake medicines wish to avoid consuming their own deadly product. As counterfeit versions of these anti-malarial medicines may continue to appear in the market and deceive people into thinking dangerous fakes are genuine, increased vigilance throughout the different supply chains is strongly advised in Cameroon and neighboring countries.

The GPHF-Minilab® is a mini-laboratory developed by the Global Pharma Health Fund to boost the medicines testing capacity at healthcare providers in developing countries. Focus of testing is on vital essential drugs, for example anti-infective medicines. It is a non-sophisticated and affordable tool fit for use in the field and it has already been supplied 630 times to 89 countries. Minilabs save lives. For more information, please visit: www.gphf.org.

blog comments powered by Disqus

Back to List

#DidYouKnow? Possession of #fakemeds is illegal, not just production or sale

India may have as much as 12-25% of their supply contaminated with substandard and #fakemeds

Every therapeutic class of pharmaceutical product has been the subject of #counterfeiting

Poisons found in #fakemeds include mercury, rat poison, boric acid, paint & antifreeze

#Fakemeds seized in Le Havre in May 2013 were hidden in sachets of tea

#Fakemeds seized during #Biyela? Antibiotics, painkillers, meds for high blood pressure & diabetes

NIH 2012 study of 7 countries in southeast Asia reveals that 36% of #antimalarials are #fakemeds

Both branded and generic products are subject to counterfeiting

More than 50% of medicine sold worldwide from illegal online sources are #fakemeds

.@INTERPO_HQ L Operation #PangeaVI seized 9.8 million illegal & counterfeit drugs #fakemeds

Of the 1mil deaths per year due to #malaria, 200,000 could be avoided if patients weren't treated with #fakemeds

60% of all spam offers medicine- its an inexpensive way for #counterfeiters to target you with #fakemeds.

#Fakemeds: 32% have no active ingredients, 40% have incorrect ingredients & dose, 8.5% contain dangerous contaminants

#Fakemeds can contain no active ingredients at all – a direct threat to patients that need treatment

#fakemeds could be up to 15% of medicines in circulation worldwide

.@UNODC estimates the market value of fake #antimalarials at over US$400mil in west Africa alone

36% of #anti-malarial drugs in #SoutheastAsia are #fakemeds

30% of countries have little or no regulation to effectively combat #fakemeds

Criminals trafficking #fakemeds make profits 10x more than those trafficking illicit drugs

123 countries are impacted by #fakemeds

Up to 40% of the drug supply of some countries in Africa could be #fakemeds

In 2013 1.2 million sachets of #fakemeds were seized in Le Havre, France. The biggest seizure in the #EU

#DidYouKnow? 96% of online pharmacies operate illegally

In 2013, Operation #Biyela seized 550 million doses of illicit medicine in #Africa

On internet sites that conceal their physical address 50% of the drugs are #fakemeds

Up to 30% of medicines in developing countries are #fakemeds

1 out of 4 counterfeit products intercepted by EU customs in 2011 were #fakemeds

1 medicine in 2 purchased on internet sites that conceal their physical address is a #fakemed

In the US only 4% of online pharmacies appear to be in compliance with pharmacy laws & practice standards

Decades of fighting #malaria could be put at risk by #fakemeds on the market

From antibiotics to pain relievers, more than 500 versions of fake #pharmaceutical products are circulating #fakemeds

700,000 people die because of #fakemeds to treat #malaria & #TB each year

2011: European Customs retained 27.5 million #fakemeds

#fakemeds are 10% to 30% of global medicine: less than 1% in some countries, +30% in parts of Africa Asia & Latin America

20% of all #malaria deaths worldwide can be directly associated with the use of #fakemeds

In 2013 US authorities published warning of fake #diabetes meds—ineffective & dangerous for patients